Galen Hepatology

Clinical research site in Chattanooga, Tennessee · 2200 E 3RD ST STE 200, CHATTANOOGA, TN 37404-2745 · (423) 643-2500

As of July 2026, 1 paid clinical trial is recruiting at Galen Hepatology in Chattanooga, Tennessee. Active studies at this site focus on Metabolic Dysfunction-Associated Steatotic Liver Disease alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Galen Hepatology (1)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

for Metabolic Dysfunction-Associated Steatotic Liver Disease

141 locations incl. Tuscaloosa

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07165028·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

More research sites in Chattanooga

Southeast Renal Research Institute (5 trials)
T C Thompson Children's Hospital (5 trials)
GSK Investigational Site (4 trials)
Tennessee Oncology, PLLC - Chattanooga Downtown (4 trials)
Tennessee Oncology, PLLC - Chattanooga Med Park II (4 trials)
Tennessee Oncology, PLLC - Chattanooga Memorial (4 trials)
Erlanger Health System (4 trials)
ClinSearch, LLC (3 trials)
Erlanger Health, Inc. (3 trials)
Tennessee Oncology (3 trials)

Explore more

Paid clinical trials in Chattanooga, TN · Tennessee clinical trials